New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...
Dr Sanjay Bhojraj, a California-based cardiologist, said that long-term melatonin use (1+ year) may increase heart failure risk by 90 percent within 5 years.